Weigen Lu
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 3
- Advancements in Transdermal Drug Delivery 2
- Co-authors
- Jing Qin (6 shared papers)Qin Guo (3 shared papers)Qinjun Chen (3 shared papers)Tao Sun (3 shared papers)Yujie Zhang (3 shared papers)Yu Zhang (2 shared papers)Chen Jiang (3 shared papers)Yifei Lü (3 shared papers)
- Journals
- International Journal of Pharmaceutics (2 papers)Advanced Science (2 papers)International Journal of Nanomedicine (2 papers)International Journal of Biological Macromolecules (1 paper)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- ChinaSouth KoreaJapan
In The Last Decade
Weigen Lu
28 papers receiving 810 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 161
- Neurology 144
- Biomaterials 227
- Complementary and alternative medicine 45
- Pharmacology 42
Countries citing papers authored by Weigen Lu
This map shows the geographic impact of Weigen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigen Lu more than expected).
Fields of papers citing papers by Weigen Lu
This network shows the impact of papers produced by Weigen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigen Lu. The network helps show where Weigen Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weigen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 162 | |
| 2 | 2018 | 149 | |
| 3 | 2007 | 99 | |
| 4 | 2019 | 68 | |
| 5 | 2018 | 57 | |
| 6 | 2007 | 52 | |
| 7 | 2019 | 35 | |
| 8 | 2023 | 30 | |
| 9 | 2008 | 29 | |
| 10 | 2019 | 21 | |
| 11 | 2018 | 21 | |
| 12 | 2016 | 16 | |
| 13 | 2008 | 15 | |
| 14 | 2022 | 14 | |
| 15 | 2019 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2022 | 6 | |
| 19 | Study on Oral Bioavailability of Baicalin in Rats | 2008 | 5 |
| 20 | 2010 | 4 |
About Weigen Lu
Weigen Lu is a scholar working on Biomaterials, Pharmaceutical Science, Neurology, Molecular Medicine and Gastroenterology, having authored 30 papers that have together received 833 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers), Neurological Disease Mechanisms and Treatments (3 papers), Pharmacological Effects of Natural Compounds (2 papers), Curcumin's Biomedical Applications (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (161 citations), Neurology (144 citations), Biomaterials (227 citations), Complementary and alternative medicine (45 citations) and Pharmacology (42 citations). Weigen Lu has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Jing Qin, Qin Guo, Qinjun Chen, Tao Sun, Yujie Zhang, Yu Zhang, Chen Jiang, Yifei Lü, Rong Xu and Jianming Liang. Their work appears in journals such as International Journal of Pharmaceutics, Advanced Science, International Journal of Nanomedicine, International Journal of Biological Macromolecules and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.